They have a licensing agreement with $RBII to produce their products. Investors were wondering if they were going to come up with a CBD only variant, & apparently they are according to this tweet:
A quick update we are currently sourcing vendors for lab tested CBD distillate for our Cannophen and TSW products for both THC/CBD & CBD only variants #cannophen#tswpaincream
— Rising Biosciences (@RisingIndiaUSA) April 4, 2019
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.